LJPC
La Jolla Pharmaceutical Company
LJPC
LJPC
Delisted
LJPC was delisted on the 19th of August, 2022.
78 hedge funds and large institutions have $670M invested in La Jolla Pharmaceutical Company in 2018 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 35 increasing their positions, 17 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
25% less capital invested
Capital invested by funds: $891M → $670M (-$221M)
68% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 25
Holders
78
Holding in Top 10
4
Calls
$5.81M
Puts
$956K
Top Buyers
| 1 | +$21M | |
| 2 | +$11.3M | |
| 3 | +$6.76M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$5.56M |
| 5 |
Barclays
London,
United Kingdom
|
+$2.8M |
Top Sellers
| 1 | -$4.57M | |
| 2 | -$2.99M | |
| 3 | -$1.64M | |
| 4 |
AG
Artal Group
Luxembourg
|
-$1.01M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$615K |